Evicenter
MarkdownMedical informationP&T meetings
Cretostimogene grenadenorepvec (CG0070)

BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Manufacturer
CG Oncology
Launch
Not announced
Last updated
161 sources

Economic information and modeling reportBudget impact modelResults

Base case

6 evidence topics · 6 sources

Budget impact model of cretostimogene grenadenorepvec: base-case results

No evidence found.

Base-case cost-effectiveness of radical cystectomy and bladder-sparing treatments over 5 years
Index patient and strategyCost (5-year USD)Effectiveness (5-year QALY)ICER (USD/QALY)Net monetary benefit
Index patient 1: gemcitabine/docetaxel“78,539”View highlighted excerpt for this quote“3.95”View highlighted excerpt for this quote“Ref.”View highlighted excerpt for this quote“316,053”View highlighted excerpt for this quote
Index patient 1: radical cystectomy“96,909”View highlighted excerpt for this quote“3.78”View highlighted excerpt for this quote“−109.912”View highlighted excerpt for this quote“280,971”View highlighted excerpt for this quote
Index patient 1: pembrolizumab“226,879”View highlighted excerpt for this quote“3.82”View highlighted excerpt for this quote“−1,137,869”View highlighted excerpt for this quote“154,677”View highlighted excerpt for this quote
Index patient 1: nadofaragene“296,318”View highlighted excerpt for this quote“3.84”View highlighted excerpt for this quote“−2,154,264”View highlighted excerpt for this quote“88,165”View highlighted excerpt for this quote
Index patient 1: NAI-BCG“529,801”View highlighted excerpt for this quote“3.85”View highlighted excerpt for this quote“−4,685,203”View highlighted excerpt for this quote“−144,840”View highlighted excerpt for this quote
Index patient 3: pembrolizumab“419,022”View highlighted excerpt for this quote“3.88”View highlighted excerpt for this quote“Ref.”View highlighted excerpt for this quote“−31,083”View highlighted excerpt for this quote
Index patient 3: nadofaragene“449,307”View highlighted excerpt for this quote“3.90”View highlighted excerpt for this quote“1,469,775”View highlighted excerpt for this quote“−59,307”View highlighted excerpt for this quote
Index patient 3: NAI-BCG“704,172”View highlighted excerpt for this quote“3.83”View highlighted excerpt for this quote“−3,847,835”View highlighted excerpt for this quote“−320.796”View highlighted excerpt for this quote